INSIGHTS ON CLINICAL TRIAL PARTNERING

• Ethical & Regulatory Considerations For Pediatric Gene Therapy

  Understanding risk thresholds, consent requirements, and IRB expectations early can prevent redesign, reduce delays, and improve trial feasibility for vulnerable patient populations

• Accelerating A Global, FIH ADC Therapy Trial For Lung Cancer

  Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.

• From Legacy To Lifeline: Advancing Rare Disease Care

  Learn about inspiring figures who lived with rare diseases, get a look at today’s rare disease research, and see how we support patients around the world in this eBook.

• The High Cost Of CRO Turnover (And How You Can Avoid It)

  Though some turnover is an inevitable part of a business’s life cycle, there are several strategies available to ensure a consistent CRO team throughout the span of your trial.

• What Does Site Engagement Actually Do?

  4/29/2026

  Site Engagement stays close to research sites, providing guidance, reducing administrative strain, and addressing issues early. Their support keeps studies moving by preventing small operational challenges from becoming delays.

• How A Biotech Startup Transformed Their Clinical Trial Supply Management

  2/25/2026

  Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.

• Rare Diseases And The Integrated CDMO Support System

  4/7/2026

  Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.

• Reduction Of Screen Failures In A Biomarker

  2/24/2026

  Targeted prescreening for biomarker and cognitive criteria cut screen failures in a complex Alzheimer’s trial, speeding enrollment and improving site efficiency while maintaining strict eligibility.

   

• Critical Imaging Risks In GLP-1 And Neurology Studies

  4/3/2025

  In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.